World News

Molecular Burglary: Cancer Cells Hijack Energy from Immune Cells

Ogkologos - 21 Νοεμβρίου, 2023

Efficacy Outcomes of Olaparib in Patients with mCRPC with BRCA Alterations...

Ogkologos - 21 Νοεμβρίου, 2023

How to Talk About Advanced Cancer Care Planning: An Expert Discussion

Ogkologos - 20 Νοεμβρίου, 2023

FDA Approves Fruquintinib for Patients with Refractory Metastatic Colorectal Cancer

Ogkologos - 20 Νοεμβρίου, 2023

FDA Amends Approval of Pembrolizumab to Treat Stomach and Esophageal Junction...

Ogkologos - 17 Νοεμβρίου, 2023

EMA Recommends Granting a Conditional Marketing Authorisation for Adagrasib Following a Re-Examination...

Ogkologos - 17 Νοεμβρίου, 2023

Spotlight On: Exercise Physiologists in Cancer Care

Ogkologos - 16 Νοεμβρίου, 2023

Adjuvant Atezolizumab Plus Bevacizumab Improves RFS Among Patients at High Risk...

Ogkologos - 16 Νοεμβρίου, 2023

Selpercatinib Slows Progression of RET-Positive Lung, Medullary Thyroid Cancers

Ogkologos - 15 Νοεμβρίου, 2023

Severe Immune-Related Gastroenterocolitis Described After in Utero Exposure to Pembrolizumab

Ogkologos - 15 Νοεμβρίου, 2023

1...102103104...432 Σελίδα 103 από 432

MOST POPULAR

NICE doesn’t recommend ibrutinib drug for those with Waldenstrom’s macroglobulinaemia

23 Μαΐου, 2022

Ellen Gifts 25K To Army Veteran Who Fought Breast Cancer And...

18 Νοεμβρίου, 2019

Neoadjuvant Chemotherapy with mFOLFIRINOX Followed by Chemoradiotherapy Improves Survival in Patients...

14 Αυγούστου, 2024

Selinexor plus Ruxolitinib Reduces Spleen Volume, but Does Not Improve Symptom...

18 Ιουνίου, 2026

Φόρτωση περισσοτέρων

Molecular Burglary: Cancer Cells Hijack Energy from Immune Cells

Efficacy Outcomes of Olaparib in Patients with mCRPC with BRCA Alterations...

How to Talk About Advanced Cancer Care Planning: An Expert Discussion

FDA Approves Fruquintinib for Patients with Refractory Metastatic Colorectal Cancer

FDA Amends Approval of Pembrolizumab to Treat Stomach and Esophageal Junction...

EMA Recommends Granting a Conditional Marketing Authorisation for Adagrasib Following a Re-Examination...

Spotlight On: Exercise Physiologists in Cancer Care

Adjuvant Atezolizumab Plus Bevacizumab Improves RFS Among Patients at High Risk...

Selpercatinib Slows Progression of RET-Positive Lung, Medullary Thyroid Cancers

Severe Immune-Related Gastroenterocolitis Described After in Utero Exposure to Pembrolizumab

MOST POPULAR

NICE doesn’t recommend ibrutinib drug for those with Waldenstrom’s macroglobulinaemia

Ellen Gifts 25K To Army Veteran Who Fought Breast Cancer And...

Neoadjuvant Chemotherapy with mFOLFIRINOX Followed by Chemoradiotherapy Improves Survival in Patients...

Selinexor plus Ruxolitinib Reduces Spleen Volume, but Does Not Improve Symptom...

HOT NEWS

FDA Approvals Expand Initial Treatment Options for Multiple Myeloma

EMA Recommends Extension of Therapeutic Indications for Osimertinib

FDA Approves Erdafitinib for Locally Advanced or Metastatic Urothelial Carcinoma

ESMO Calls on the European Commission to Fund Cancer Research and...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ